Moderna Hiring 300 AI and mRNA Scientists in Cambridge
Moderna announced 300 new positions in AI-driven drug design, mRNA biology, and clinical operations as the biotech company expands beyond COVID vaccines into oncology, rare diseases, and respiratory vaccines.
Why Is the Company Hiring?
mRNA pipeline has expanded to 45 programs across oncology, rare diseases, and infectious diseases
AI-powered mRNA sequence optimization is accelerating candidate development timelines
Post-COVID revenue normalization requires diversified pipeline execution to sustain valuation
Competition from BioNTech, Pfizer, and CureVac in mRNA therapeutics is intensifying
Impact Analysis
Roles are based at Moderna's expanded Cambridge (Kendall Square) campus and new Norwood, MA manufacturing facility. The company is specifically recruiting computational biologists, protein engineers, and machine-learning scientists. Moderna's hiring contributes to Cambridge's growing dominance as the biotech capital of the world, where lab and office space commands some of the highest rents globally.